Skip to main content

Leukemia

Leukemia, Value-Based Care

First National Study: Geographic Socioeconomic Disparities Mirror Substantial Gaps in Survival in Children with AML

Chase Doyle

First-Line Acalabrutinib-Based Triplet Therapy Leads to Undetectable Minimal Residual Disease in CLL

Wayne Kuznar

Investigational Oral Form of Azacitidine Improves Survival Maintenance Therapy in Patients with Acute Myeloid Leukemia

Wayne Kuznar

Venetoclax plus Intensive Chemotherapy Shows Promising Results in All Patients with Acute Myeloid Leukemia

Chase Doyle

Zanubrutinib, Next-Generation BTK, Leads to Impressive Responses in Patients with CLL or SLL

Phoebe Starr

In the News, Leukemia

November 4, 2019 — Oncology News & Updates

Fixed-Duration Targeted Therapy with Venetoclax plus Obinutuzumab New Front-Line Standard for Patients with Chronic Lymphocytic Leukemia

Phoebe Starr

Read More

Leukemia

Gilteritinib and CX-01 in the Treatment of Patients with Acute Myeloid Leukemia

Phoebe Starr

Phoebe Starr

Read More

Leukemia

First-Line Enasidenib Achieves Complete Remission in Older Patients with Acute Myeloid Leukemia and IDH2 Mutation

Charles Bankhead

Charles Bankhead

Read More

Leukemia

First-Line Ibrutinib Improves Outcomes Compared with Current Standard of Care in Older Patients with Chronic Lymphocytic Leukemia

Wayne Kuznar

Wayne Kuznar

Read More

1
2
3
4
5

Page 2 of 7
Results 11 - 20 of 70

SUBSCRIBE

HOME

ABOUT

CONTACT US

TERMS OF USE

PRIVACY POLICY

ADVERTISING POLICY

© Amplity Health. All rights reserved.

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

AHDB Special Print Editions

AHDB Weekly e‑Newsletter

I have reviewed and consent to the terms of AHDB's Privacy Policy, and AHDB has my permission to retain my information in its database, and to forward pertinent communications to me.